---
title: "Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285701166.md"
description: "CFRA has maintained a Hold opinion on Smith & Nephew (SNN) and lowered its target price from USD37 to USD33, reflecting a 2026 P/E of 14.8x. The company reported a Q1 2026 revenue growth of 3.1%, with challenges in the U.S. Knee Implant sector. Despite this, Smith & Nephew reiterated its 2026 guidance of 6% revenue growth and USD1.3B trading profit. The upcoming cementless LANDMARK launch is seen as a crucial factor for addressing issues in the knee business."
datetime: "2026-05-08T09:40:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285701166.md)
  - [en](https://longbridge.com/en/news/285701166.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285701166.md)
---

# Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew

05:40 AM EDT, 05/08/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our target price to USD33 from USD37, implying a 2026 P/E of 14.8x. This is broadly in line with its three-year historical forward P/E of 15x. While we see positives from its stronger positioning following the completion of the 12-Point Plan and additional upside from the RISE strategy, our optimism is tempered by rising execution risk in the U.S. Knee Implant business. Our EPS estimates remain unchanged. Smith & Nephew's ( SNN ) Q1 2026 underlying revenue growth of 3.1% decelerated sequentially across all segments, particularly Orthopaedics due to U.S. Knee Implants weakness. SN reiterated its 2026 guidance of 6% underlying revenue growth and USD1.3B trading profit. We expect upcoming launches and continued execution of the RISE strategy to support growth momentum, but execution on U.S. Knee Implants remains critical to monitor. The cementless LANDMARK launch is an important catalyst to address persistent challenges in the knee business, in our view.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [SNN.US](https://longbridge.com/en/quote/SNN.US.md)

## Related News & Research

- [Smith & Nephew Sets Sterling Rate for 2025 Final Dividend Ahead of May 27 Payout](https://longbridge.com/en/news/286132889.md)
- [Smith & Nephew AGM Approves All Resolutions Amid Pushback on Pay Plans](https://longbridge.com/en/news/285398319.md)
- [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md)
- [Keysight Technologies Reports Second Quarter 2026 Results | KEYS Stock News](https://longbridge.com/en/news/286959830.md)
- [Correction: NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET | NXXT Stock News](https://longbridge.com/en/news/286673001.md)